Monitoring Agency Report for the Quarter ended 30th September, 2025
POLYMED · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Awaiting price reaction for this filing.
Poly Medicure Limited has submitted the quarterly Monitoring Agency Report for the quarter ended 30th September, 2025, as required under SEBI regulations. A monitoring agency is appointed by companies that raise money from the public through IPOs, FPOs, or rights issues, and it independently reviews whether the company is using those funds for the purposes disclosed at the time of the issue. This is a routine compliance filing submitted every quarter until the entire amount raised is fully utilized. The report itself confirms the status of fund deployment as tracked by the appointed monitoring agency. The actual details would be available in the full report attached to the filing on the NSE portal.
This is a standard regulatory disclosure and typically has no direct impact on the stock price. It reassures shareholders that the funds raised from earlier public issues are being monitored and used as planned, adding a layer of transparency and governance.